GE HealthCare Anesthesia Systems Recall
potentially life-threatening risk in Volume Control Ventilation (VCV) modeGE Carestation Anesthesia Systems
GE HealthCare has issued a high-priority correction for certain Carestation anesthesia systems due to a potentially life-threatening risk when used in Volume Control Ventilation (VCV) mode.
Affected Devices
- Carestation 620, 650, 650c
- Carestation 750, 750c
These systems are used in hospitals and surgical settings for delivering anesthesia and ventilatory support to patients of all ages.
The Problem
In VCV mode, the devices affected may fail to ventilate properly. If this happens:
- Alarms and warnings will be triggered (e.g., bellows stop moving, “Unable to Drive Bellows” message, apnea alerts).
- If uncorrected, this can lead to serious injury or death from hypoxia (low oxygen levels).
What to Do
GE HealthCare recommends:
- Do NOT use VCV mode until the device is corrected.
- Use only:
- Pressure Control Ventilation (PCV)
- Pressure Control Ventilation Volume Guarantee (PCV-VG)
- Or manual ventilation
- Perform a Ventilation Screening Test on each system.
- Train your staff and ensure they are aware of the risk and temporary workaround.
- Return the Acknowledgement Form provided in the correction notice.
Questions?
Call GE HealthCare Service at 1-800-437-1171.
If your facility uses these systems, take immediate action to prevent harm. GE HealthCare is currently correcting the devices — no need to remove them from service if alternate modes are used safely.
Urgent Recall Notice for ARROW QuickFlash Catheterization Kits
Urgent Recall Notice for ARROW QuickFlash Catheterization Kits In February 2024, Teleflex and its subsidiary Arrow International issued an urgent recall notice for the ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits. Today, a...
Plastic Syringe Safety: FDA’s Ongoing Evaluation
Today, the U.S. Food and Drug Administration (FDA) provided a crucial update regarding the quality and performance issues associated with plastic syringes made in China. This announcement follows the agency's previous safety communication issued on November 30, 2023,...
Original FDA Safety Warning for China-made Syringes
In an announcement dated November 30, 2023, the U.S. Food and Drug Administration (FDA) issued a notice regarding the evaluation of potential device failures associated with plastic syringes manufactured in China. The FDA is actively collecting and analyzing data to...